₹-2.25
(Market cap
₹72 Cr
Revenue (TTM)
₹133 Cr
P/E Ratio
18.3
P/B Ratio
1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹7 Cr
-
ROE
10.9 %
-
ROCE
13 %
-
Industry P/E
39.17
-
EV/EBITDA
7
-
Debt to Equity
0.7
-
Book Value
₹40.5
-
EPS
₹4.2
-
Face value
10
-
Shares outstanding
17,148,800
5 Years Aggregate
CFO
₹-18.98 Cr
EBITDA
₹53.69 Cr
Net Profit
₹27.88 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zenith Drugs
| -16.1 | -8.4 | -12.2 | -38.6 | -- | -- | -- |
|
BSE Healthcare
| 18.7 | 1.7 | 10.2 | 18.2 | 22.8 | 14.5 | 12.3 |
|
Company
|
2025
|
|---|---|
|
Zenith Drugs
| -39.6 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Zenith Drugs
|
42.1 | 72.2 | 133.3 | 7.2 | -- | 10.9 | 18.3 | 1.0 |
| 1,405.7 | 17,237.7 | 2,590.4 | 603.0 | 29.3 | 19.6 | 28.6 | 4.9 | |
| 578.8 | 10,929.7 | 885.7 | 234.9 | 27.8 | 18 | 46.5 | 4.9 | |
| 1,446.1 | 15,167.3 | 1,108.4 | 270.2 | 28.3 | 14.5 | 55.1 | 7.3 | |
| 1,855.3 | 35,217.7 | 9,683.5 | 1,019.0 | 15.7 | 21.3 | 34.8 | 6.7 | |
| 23,010.0 | 29,424.3 | 2,371.8 | 497.8 | 28.0 | 28.5 | 59.1 | 14.6 | |
| 970.9 | 5,781.6 | 942.6 | 9.9 | 0.3 | 1.2 | 667.2 | 4.4 | |
| 1,432.8 | 6,599.7 | 691.7 | 130.8 | 24.5 | 14.5 | 52.2 | 6.8 | |
| 1,209.7 | 13,670.7 | 675.6 | 183.6 | 32.2 | 22.7 | 74.9 | 14.8 | |
| 392.1 | 11,087.8 | 8.8 | -352.4 | -4,228.0 | -80.8 | -- | 19.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Zenith Drugs
--
-
Incorporated
2000
-
Chairman
--
-
Managing Director
Sandeep Bhardwaj
-
Headquarters
Indore, Madhya Pradesh
-
Website
Looking for more details about Zenith Drugs Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Zenith Drugs
What is the current share price of Zenith Drugs Ltd Today?
The share price of Zenith Drugs Ltd is ₹42.10 (NSE) as of 31-Aug-2026 IST. Zenith Drugs Ltd has given a return of -38.58% in the last 1 years.
What is the current PB & PE ratio of Zenith Drugs Ltd?
The P/E ratio of Zenith Drugs Ltd is 18.31 times as on 31-Aug-2026, a 53 discount to its peers’ median range of 39.17 times.
The P/B ratio of Zenith Drugs Ltd is 1.04 times as on 31-Aug-2026, a 71 discount to its peers’ median range of 3.61 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
17.17 |
1.77 |
2024 |
11.21 |
1.73 |
2023 |
0.00 |
0.00 |
2022 |
0.00 |
0.00 |
2021 |
0.00 |
0.00 |
What is the 52 Week High and Low of Zenith Drugs Ltd?
The 52-week high and low of Zenith Drugs Ltd are Rs 73.45 and Rs 33.30 as of 01-Sep-2026.
What is the market cap of Zenith Drugs Ltd?
Zenith Drugs Ltd has a market capitalisation of ₹ 72 Cr as on 31-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Zenith Drugs Ltd?
Before investing in Zenith Drugs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.